STAT | A decade of reporting from the frontiers of health and medicine Overview & Contact Data

STAT is a prominent online news organization that specializes in in-depth reporting on the latest developments in health, science, and medicine. Founded in 2013, the company has established itself as a trusted source for authoritative and insightful coverage of the biotech and pharmaceutical industries. STAT's reporting team consists of experienced journalists and writers who provide context and analysis on the complex issues shaping the healthcare landscape. The company's primary audience consists of professionals working in the healthcare and biotech sectors, including pharmaceutical executives, researchers, investors, and clinicians. STAT's content is geared towards providing timely and accurate information on regulatory developments, clinical trials, and emerging trends in the life sciences. The website also features a section dedicated to analysis and commentary on the latest headlines in biotech, offering readers a deeper understanding of the industry's most significant stories. One of STAT's notable features is its STAT+ subscription service, which offers exclusive content and analysis on biotech, pharma, and the life sciences. This premium service provides readers with access to in-depth reporting, expert insights, and data-driven analysis on the latest trends and developments in the industry. STAT's commitment to high-quality reporting and its focus on the intersection of science and policy have earned it a reputation as a go-to source for professionals working in the healthcare and biotech sectors.